FIELD: medical virology.
SUBSTANCE: invention relates to medical virology. The proposed vaccine strain A/17/Newcastle/2018/22 (H3N2) is a reassortant obtained by crossing the epidemic virus A/Newcastle/82/2018 (H3N2) (A/South Australia/34/2019-like) with a cold-adapted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) - an attenuation donor, harmless to humans.
EFFECT: proposed strain can be used for the production of a live intranasal influenza vaccine for adults and children.
1 cl, 1 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SYDNEY/2019/156 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783876C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SOUTH AUSTRALIA/2019/122 (H3N2) FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783877C1 |
| VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/SWITZERLAND/2017/51 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2715674C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2017/7178 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2711101C1 |
| REASSORTANT VACCINE STRAIN OF INFLUENZA VIRUS A/17/TASMANIA/2020/151 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2023 |
|
RU2825672C1 |
| REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/HONG KONG/2019/2573 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783894C1 |
